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In order to evaluate whether bovine herpesvirus-1 (BHV-1) could be used as a live viral vector for the expression of
cytokines, we constructed a recombinant BHV-1 expressing bovine interleukin-1b (boIL-1b). The boIL-1b coding sequence,
corresponding to the cleaved mature product, was fused with the BHV-1 glycoprotein C (gC) signal peptide sequence; the
resultant gC-boIL-1b fusion gene was recombined into the gC locus of the BHV-1 genome. Southern blot analysis confirmed
the proper genomic configuration of the recombinant virus. Results from transcript analysis showed that boIL-1b was
expressed in infected cells with kinetics similar to that of gC. Indirect immunofluorescence and immunoprecipitation assays
showed that the recombinant protein was produced in both cell-associated and secreted forms. Western blot analysis
detected a 19.3-kDa protein. Further analysis, using an IL-1b bioassay demonstrated that both the cellular and secreted
forms of recombinant boIL-1b possessed biological activity. The expression of the boIL-1b protein did not affect the in
vitro growth efficiency of the virus, which exhibited similar growth kinetics to that of a simple gC deletion mutant. The
results from this study demonstrate that BHV-1 can be used to express a functional cytokine, thereby establishing the basis
to further study recombinant BHV-1 expressing cytokines as an alternative means to attenuate the virus and also as a
potential in situ cytokine delivery system to modulate immune responses against BHV-1 and other cattle pathogens.
q 1996 Academic Press, Inc.
INTRODUCTION to deliver cytokines to the site of infection are being
investigated. These include the creation of chimeric mol-
Cytokines have a central role in the initiation and differ-
ecules, delivery vehicles, and the use of viral vectors to
entiation of the immune system and in regulating both the
express cytokines (Hughes et al., 1992; Pardoll, 1995;
type and magnitude of the immune response. Cytokine
Ramshaw et al., 1992).
regulation during disease progression has been well
Bovine herpesvirus-1 (BHV-1) belongs to the subfamily
demonstrated in both parasitic and bacterial infections
Alphaherpesvirinae of the family Herpesviridae. BHV-1
(Powrie and Coffman, 1993). For example, in Mycobacte-
causes infectious bovine rhinotracheitis, a contagious
rium leprae infections, T helper subset 1 (TH1) cells se-
viral disease that produces substantial economical loss
crete interleukin-2 (IL-2) and interferon-g, resulting in the
in the cattle industry (Wyler et al., 1989). BHV-1 is also
induction of a cell-mediated response that is associated
the major viral pathogen in the development of the respi-
with resistance. In contrast, TH2 cells that produce IL-4
ratory disease complex commonly referred to as ship-
and IL-10 are associated with progressive disease (Sei-
ping fever (Yates, 1982). Current interest in vaccine devel-ling and Modlin, 1994). Because of the central role that
opment has focused on the use of subunit vaccines, genecytokines play in the immune response, researchers
deleted, killed, or live viral vaccines (van Drunen Littel-have attempted to use cytokines to enhance the immune
van den Hurk et al., 1993; van Oirschot, 1994). Attemptsresponse in both therapeutic treatments and in vaccine
at attenuating BHV-1 for use in vaccines have focusedformulations (Heath and Playfair, 1992). However, since
on the creation of different deletion mutants (Kit et al.,cytokines have a short half-life and largely function within
1985; Liang et al., 1991; Kaashoek et al., 1994). The ex-a limited microenvironment, their usefulness has been
pression of cytokines by a recombinant virus could po-hampered by the need for large doses administered sys-
tentially function as an alternative means to attenuatetemically which can sometimes result in toxic side effects
and increase the immune response to the recombinant(Haworth and Feldman, 1991). Therefore, new methods
virus.
Interleukin-1b (IL-1b) has been used as an immuno-
logical adjuvant because of its ability to influence a1 To whom correspondence and reprint request should be ad-
dressed. Fax: (306) 966-7498. broad spectrum of biological activities within the
2 Current address: Queensland Institute of Medical Research, Bris-
haematopoietic and immunological systems (Dinarello,bane, Queensland, 4029, Australia.
1991). For example, it has been shown that the coad-3 Current address: Department of Cellular and Molecular Biology,
Merck Research Laboratories, Rahway, NJ 07065. ministration of recombinant bovine IL-1b (boIL-1b) and
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a modified live BHV-1 vaccine was able to enhance Bam/ (step 2). This resulted in pSD113SSBam, which
contains the 1-kb gC 5* flanking sequence, gC signalboth the humoral and cellular immune response
against BHV-1 (Reddy et al., 1990, 1993). Therefore, peptide sequence, signal peptide cleavage site, and a
SmaI–BamHI– SmaI cloning site and an 1-kb 3* gC flank-we have chosen boIL-1b to evaluate the potential of
utilizing BHV-1 for the expression of cytokines. This ing sequence. The boIL-1b coding sequence was iso-
lated from plasmid pBIL1b3.3 (CIBA-GEIGY, Basel, Swit-would create a system for investigating immunomodu-
lation caused by cytokine delivery at the site of infec- zerland) by Mae III and Mae II digestion (Leong et al.,
1988). After treating with Klenow fragment, the IL-1b frag-tion, and also, for investigating possible attenuation of
BHV-1 and reducing opportunistic pathogens associ- ment was cloned into the BamHI site of pSD113SSBam
which had been blunted with Klenow fragment (step 3).ated in the development of the respiratory disease com-
plex initiated by BHV-1. As a first step, we constructed This resulted in pSD113SSIL-1b, a transfer vector that
contains the mature sequence of boIL-1b fused with thea BHV-1 recombinant virus expressing boIL-1b at the
gC locus and characterized its in vitro properties. gC signal peptide sequence (Fig. 1B).
Purification of virus and viral DNAMATERIALS AND METHODS
Virus was purified as previously described (Babiuk etVirus and cells
al., 1975). Briefly, MDBK cells were infected at a multiplic-
The Cooper strain of BHV-1, obtained from the Na- ity of infection (m.o.i.) of 1. After the cells exhibited com-
tional Veterinary Services Laboratory (Ames, Iowa), plete cytopathology, the supernatants containing the vi-
was used as the prototype virus; a gC-negative mutant rus were clarified by low-speed centrifugation at 1000 g.
was previously produced in this laboratory (Liang et al., Virus was harvested by pelleting the clarified supernatant
1991). The viruses were propagated in Madin – Darby through a 30% sucrose in phosphate-buffered saline
bovine kidney (MDBK) cells grown in minimum essen- (PBS) cushion at 100,000 g for 60 min. The virus pellet
tial medium (MEM) (GIBCO Laboratories, Grand Island, was then resuspended in 0.05 M Tris–HCl, 0.15 M NaCl,
NY) supplemented with 10% fetal bovine serum (FBS; 10 mM EDTA (pH 8.0) and applied to a 20 to 50% potas-
GIBCO/BRL). sium-sodium tartrate discontinuous gradient and centri-
An IL-1 responsive cell-line (LM-1) was subcloned fuged at 100,000 g for 90 min. After centrifugation, the
from the murine helper T-cell line D10.G4.1 (Kaye et al., virus band was collected, diluted in PBS, and pelleted at
1983) as previously described (Orencole and Dinarello, 75,000 g for 60 min. Purified virus was stored at 0707C.
1989). Briefly, D10.G4.1 cells, which grew in the absence Viral DNA was purified according to the method of
of conalbumin and spleen feeder cells, were subcloned Summers and Smith (1987). Purified virus was sus-
and analyzed for sensitivity to IL-1. One subclone, desig- pended in extraction buffer (0.1 M Tris–HCl, 0.15 M NaCl,
nated LM-1, was used for the IL-1 bioassay. LM-1 cells 0.1 M EDTA, 0.1 M KCl, pH 7.5) containing 45 mg of
were maintained in Click’s Media (Irvine Scientific, Santa proteinase K (Sigma Chemical Co., St. Louis, MO) per
Ann, CA) supplemented with 10% FBS (Hyclone, Logan, milliliter and incubated at 507 for 1 hr. Sarkosyl was
Utah), 2 mM L-glutamine, and 10% Con A-stimulated rat added to a final concentration of 1%, and the sample
spleen supernatant. was incubated at 507 for an additional 1 hr. The sample
was extracted twice with phenol-chloroform-isoamyl al-
Construction of transfer vector cohol (25:24:1) and precipitated with ethanol. The DNA
pellet was resuspended in 0.05 M Tris–HCl, 10 mM
To construct the transfer vector, p113RI-Bgl3.0, a sub-
EDTA, pH 8.0, aliquoted, and stored at 0707.
clone derived from pSD113 (Mayfield et al., 1983) con-
taining the gC sequence, was digested with BamHI and Recombinant virus production
PvuII; the plasmid backbone was treated with Klenow
fragment and ligated with a Klenow-treated, 1-kb BamHI – Recombinant viruses were produced by cotransfection
of MDBK cells with pSD113SSIL1-b plus naked BHV-1PvuII gC 5* fragment from pSD113. This extended the 5*
flanking sequence and converted the BamHI site 61 bp genomic DNA by electroporation (Chu et al., 1987).
Briefly, MDBK cells were trypsinized, resuspended in ice-upstream of the gC translation initiation codon into a ClaI
site. The resultant plasmid is named as pSD113EClaH/P cold HEPES-buffered saline (HeBS; 20 mM HEPES [N-
2-hydroxyethylpiperazine-N *-2-ethanesulfonic acid], 137(Fig. 1A). pSD113EClaH/P was digested with SalI, blunted
with Klenow fragment, and ligated with a BamHI linker mM NaCl, 5 mM KCl, 0.7 mM NaHPO4 , 5 mM D-glucose,
pH 7.1), and washed three times in HeBS at 47. After the(CGGGATCCCG) (Fig. 1, step 1), resulting in pSD113Sal-
Bam/. A 68-bp NcoI– BamHI fragment containing the final wash, cells were resuspended to 3 1 106 cells/ml
in HeBS and transferred to an electroporation cuvettegC signal peptide sequence was isolated from plasmid
pRSVgCSSbam (Fitzpatrick, unreported results) and used (Bio-Rad Laboratories, Richmond, CA) containing 10 mg
of linearized plasmid DNA and 20 mg of viral DNA. Elec-to replace the NcoI and BamHI fragment of pSD113Sal-
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troporation was performed at 500 mF and 200 V using a saturated with 100 mM Tris Chloride (pH 8). The aqueous
phase was equilibrated to 0.3 M in sodium acetate (pHBio-Rad Gene Pulser. The cells were then transferred to
a 100-mm culture dish containing 15 ml of MEM with 5.5) by adding 40 ml of 3 M sodium acetate. The RNA
was precipitated with ethanol and resuspended in H2O.10% FBS, incubated at 377 for 5 hr, and overlaid with 1%
agarose containing 2% FBS in MEM. gC-negative virus Equal amounts of infected cell RNA (3 mg) purified at
various times postinfection were separated on a 1.2%plaques were screened by an antibody-based black-
plaque assay. agarose-formaldehyde gel and hybridized as previously
described (Maniatis et al., 1982).
Black-plaque assay
Indirect immunofluorescence assay
The black-plaque assay was carried out by the method
MDBK cells cultured in chamber slides (Nunc Inc.,of Johnson et al. (1986). Briefly, the MDBK cell monolayer
Naperville, IL) were infected with recombinant virus at awith an appropriate number of viral plaques were fixed
m.o.i. of 0.01 for 16 hr, fixed with 2% paraformaldehydewith 0.25% glutaraldehyde (Sigma) in PBS, pH 7.2, for 3
for 5 min, and permeabilized with methanol at 0207 formin, washed three times with PBS, and blocked for 1 hr
15 min. Nonspecific reactions were blocked by treatingwith 1% bovine serum albumin (BSA; Sigma) in PBS (BSA-
slides with 2% BSA and 2% normal goat serum in PBSPBS). An anti-gC monoclonal antibody (MAb) pool (van
(blocking solution) for 30 min. Afterwards, slides wereDrunen Littel-van den Hurk et al., 1984), diluted to 1:1000
incubated with rabbit anti-boIL-1b serum at 1:500 dilutionin BSA-PBS, was added to the plates and incubated for 1
for 1 hr. Rabbit anti-boIL-1b serum was produced againsthr at room temperature. Cells were then washed three
recombinant bovine IL-1b (American Cynamid, Princeton,times with PBS, followed by the addition of peroxidase-
New Jersey). After washing, slides were stained with fluo-conjugated goat anti-mouse immunoglobulin G (IgG; Boe-
rescein isothiocyanate-conjugated goat anti-rabbit anti-hringer Mannheim, Dorval, Quebec, Canada, 1:2000 in
body at an 1:80 dilution in blocking solution (Bio-Rad,BSA-PBS). After an additional hour of incubation, the
Mississauga, Canada). Slides were mounted in citifluorplates were again washed three times with PBS, followed
glycerol (Ted Pella, Inc., Redding, CA) and examined withby the addition of 0.01% 4-chloronaphthol (Sigma) and
a fluorescence microscope.0.0003% H2O2 (Sigma) in water. The plates were incubated
at room temperature until black plaques developed. Immunoprecipitation
Immunoprecipitation was performed as previously de-Southern analysis
scribed (Liang et al., 1991). Briefly, subconfluent mono-
Viral DNA was isolated from wild-type and recombi- layers of MDBK cells were infected with respective vi-
nant virus as previously described (Liang et al., 1992). ruses at a m.o.i. of 10 and labeled with 50 mCi of L-
The DNA was digested with EcoRI and BglII restriction [35S]methionine (Amersham, Oakville, Ontario, Canada)
endonucleases, run on a 1% agarose gel, and transferred per milliliter of medium, for 24 hr. After labeling, the cellu-
to nitrocellulose filter using standard procedures (Ma- lar and supernatant fractions were harvested separately
niatis et al., 1982). The nitrocellulose filter was hybridized and precipitated with rabbit anti-boIL-1b antibody. The
with 32P-labeled DNA probes corresponding to the boIL- antibody precipitated samples were separated on SDS–
1b gene and the 5* noncoding region of the gC gene 10% polyacrylamide gels under reducing conditions.
(0.6-kbp SmaI– BamHI fragment from pSD113SSIL-1b).
Western blot analysis
Northern blot hybridization analysis
Western blot procedures were carried out as de-
scribed previously (van Drunen Littel-van den hurk et al.,RNA preparation was performed as previously de-
scribed (Kowalski and Denhardt, 1989). Briefly, confluent 1984). Briefly, samples were prepared by concentrating
36-hr-postinfection supernatant by ultrafiltration using aMDBK cells in 100-mm plates were infected with recom-
binant virus at a m.o.i. of 10. At various time points, cells Centricon-10 (Amicon, Beverly, MA). Samples containing
2 ng of boIL-1b were denatured and resolved by electro-were washed once in phosphate-buffered saline lacking
calcium and magnesium and harvested into 200 ml of phoresis in a 10% polyacrylamide–SDS gel (Mini-pro-
tean, Bio-Rad) and transferred to a nitrocellulose sheet.TSM [30 mM Tris–HCl (pH 8), 100 mM NaCl, 1.5 mM
MgCl2]. Nonidet P-40 was added to a final concentration The protein was detected with a 1:500 dilution of a rabbit
polyclonal antibody raised against rBoIL-1b. The second-of 0.5%, and the sample was incubated on ice for 30 min
and pipetted with a 200-ml Gilson disposable tip. Nuclei ary antibody was a horseradish peroxidase-conjugated
goat anti-rabbit IgG at a 1:1000 dilution (Bio-Rad).were removed by centrifugation at 15,000 g for 10 min.
The cytoplasmic extract was added to 200 ml of lysis
Single step growth curvebuffer [2% sodium dodecyl sulfate (SDS), 7 M urea, 350
mM NaCl, 2 mM EDTA, 10 mM Tris–HCl (pH 8)] and Confluent MDBK cells grown in 6-well plates were in-
fected at an m.o.i. of 5 with either gC0, wild-type virusextracted once with 400 ml of phenol-chloroform (1:1)
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or BHV-1 expressing IL-1b (BHV/IL1b) or. After 1 hr ad- secretory proteins, IL-1b does not contain a signal pep-
tide sequence for secretion (Dinarello, 1991). Consider-sorption at 377, the virus inoculum was removed; cells
were washed with MEM and incubated with 2 ml of MEM ing these unique characteristics of IL-1b, we chose to
fuse a gC signal peptide to the amino terminus of thesupplemented with 10% FBS. At various times postinfec-
tion, aliquots of culture media were collected and as- cleaved functional protein, thereby generating a gC-IL1b
fusion molecule that could be efficiently secreted. Oursayed for viral titers.
cleaved product would be predicted to retain the 153
amino acids associated with mature bovine IL-1b plusBioassay for IL-1 activity
three additional amino acids from the gC signal se-
LM-1 cells (see above) cultured for 5 to 7 days were quence (Fig. 1B). Recombinant BHV-1 virus expressing
washed three times in Click’s media and resuspended bovine interleukin 1b was produced by homologous re-
in Click’s media with 5% FBS and 2 mM L-glutamine. The combination between the transfer vector pSD113SSIL-
samples to be tested were filtered through Centricon-30 1b and purified BHV-1 DNA cotransfected into MDBK
ultrafiltration devices (Amicon) to remove virus from the cells. Progeny viruses were screened by a black plaque
supernatant and serially diluted in a 96-well plate. Bioas- assay utilizing a pool of monoclonal antibodies against
says using LM-1 cells (2 to 4 1 105 cells/ml) were per- gC. A gC-negative white plaque was identified and desig-
formed in triplicate in 96-well polystyrene flat bottom mi- nated ‘‘BHV/IL1b.’’ After an additional two rounds of
crotiter plates at volumes of 200 ml/well and incubated plaque purification, the gC-negative mutants were used
for 72 hr at 377 in 5% CO2 . Biological activity was deter- for further characterization.
mined by adding [3H]thymidine (Amersham, 0.4 mCi/well) To ascertain that the gC-negative mutant indeed con-
18 hr prior to harvest. Incorporation of radioactivity by tained the boIL-1b gene and also to confirm the genomic
LM-1 cells was determined by scintillation counting arrangement at the gC region, Southern blot analysis
(Beckman). Relative activity of each sample was calcu- was carried out. Viral DNA from both wild-type virus and
lated as previously described (Maliszewski et al., 1988). recombinant virus (BHV/IL1b) was digested with EcoRI
One unit of IL-1 activity was defined as the amount of and BglII, separated on a 1% agarose gel, and probed
lymphokine that induced 50% of maximal proliferation in with a 0.6-kbp SmaI–BamHI gC 5* fragment from
200-ml cultures. pSD113SSIL-1b (Fig. 2). The results of the Southern anal-
Recombinant bovine IL-1b 6.8 mg/ml (American Cya- ysis were consistent with what would be predicted from
namid Co., Princeton, NJ) was used as our standard. The the transfer vector. In the wild-type viral DNA, a 3.0-kb
rBoIL-1b standard had a specific activity of 4.6 1 108 fragment hybridized to the 5* gC probe, whereas the
U/mg when assayed with LM-1 cells. The specific activity mutant virus DNA had a 2.3-kb fragment. When BoIL-1b
of recombinant boIL-1b produced by BHV/IL1b was cal- was used as a probe, no signal was detectable in the
culated using the LM-1 bioassay and a capture ELISA wild-type BHV-1 DNA; in contrast, a band of approxi-
consisting of an ovine Mab 3.41 (gift from Dr. Andrew mately 2.3-kb was detected in the mutant DNA. The re-
Nash) and a polyclonal rabbit anti-boIL-1b antibody. The sults from the Southern blot analysis confirmed that BHV-
capture ELISA was performed by coating a 96-well plate 1/IL1b contained the boIL-1b gene in the expected con-
with 100 ml of a 1:250 dilution of MAb 3.41 ascites in figuration.
carbonate buffer overnight at 47. After three washes with
PBS / 0.05% Tween 20, plates were blocked with 1% Detection of boIL-1b transcripts in virus infected cells
w/v gelatin in PBST for 1 hr at room temperature, and
As a first step to assess the expression of boIL-1b, asthen samples and rBoIL-1b standard were serially di-
well as to define the kinetics of IL-1b expression duringluted in duplicate and incubated for 2 hr at room tempera-
viral infection, boIL-1b transcripts were analyzed in BHV/ture. After washing, the polyclonal rabbit anti-boIL-1b
IL1b-infected cells by Northern analysis. In order to con-antiserum was added at a 1:3000 dilution and incubated
trol for the amount of RNA in each lane, a parallel gelfor 1 hr. After further washing, a 1:1000 dilution of horse-
was run and stained with ethidium bromide to highlightradish peroxidase-congated goat anti-rabbit IgG (Bio-
the 28S and 18S bands (top panel Fig. 3). As shownRad) was added for an additional 1 hr. The assay was
in Fig. 3 (bottom panel), boIL-1b transcripts were firstdeveloped using an ABTS substrate.
detected at 6 hr postinfection followed by a gradual in-
crease until 10 hr.RESULTS
Construction of recombinant virus Expression of boIL-1b protein by recombinant virus
Having identified the transcripts of boIL-1b, we wantedIL-1b is initially synthesized as a 31-kDa precursor
which is cleaved by an IL-1b converting enzyme (ICE) to determine whether the protein was produced in in-
fected cells. To achieve this, we first reacted infectedinto a 17.5-kDa mature cytokine (Kostura et al., 1989;
Cerretti et al., 1992; Thornberry et al., 1992). Unlike most cells with rabbit antibody against boIL-1b followed by
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FIG. 1. Construction of transfer vector pSD113SSIL-1b. (A) Striped bars represent the gC gene fragment, solid bars represent the gC signal
sequence, dotted bars represent the gC flanking sequence, tire marks represent boIL-1b, and the solid line signifies the pBR322 backbone (see
details for procedures under Materials and Methods). (B) Amino acid sequences at the junction between the gC signal peptide and mature BoIL-
1b protein. The fusion protein retains the Asp and Ala sites associated with cleavage of the precursor protein into the 153 amino acid mature
cytokine. The predicted signal sequence cleavage site is indicated by an arrow.
reaction with fluorescein-labeled goat anti-rabbit anti- BHV/IL1b produced a biologically active molecule
body. At 16 hr postinfection, infected cells showed bright
To determine whether the boIL-1b protein ex-
cytoplasmic fluorescence (Fig. 4). No fluorescence was
pressed by the recombinant virus possessed biologi-
detected in control slides infected with wild-type virus.
cal function, a bioassay for IL-1 was carried out using
To confirm that the boIL-1b expressed by the recom-
a subclone of D10.G4.1 (LM-1) (Kaye et al., 1983). Since
binant virus had the predicted molecular weight, an
the boIL-1b was secreted into the medium, we col-immunoprecipitation assay was performed. After 24 hr
lected supernatant samples from BHV1/IL1b, gC0,postinfection, cellular and supernatant fractions were
wild-type virus, and mock-infected MDBK cells. Ascollected separately and immunoprecipitated with
shown in Fig. 6, IL-1 activity was detected 24 hr postin-anti-boIL-1b antibody. A polypeptide with an apparent
fection in BHV/IL-1b-infected supernatant while no ac-molecular weight between 17 and 20 kDa was recog-
tivity was detected in the controls. Based on our LM-nized in both the supernatant and cellular fraction of
1 bioassay, we calculated the level of boIL-1b ex-BHV1/IL1b-infected cells, but not in the wild-type virus-
pressed at 24 and 36 hr to be approximately 160 unitsinfected cells (Fig. 5A). This indicated that boIL-1b was
ml01 and 320 units ml01, respectively. In addition, weindeed produced by the recombinant virus and was
calculated the specific activity of the boIL-1b producedalso secreted into the medium, as would be predicted
by BHV/IL-1b to 4.3 1 108 U/mg which was similar toconsidering that the boIL-1b protein contained a gC
the specific activity of our rBoIL-1b standard producedsignal peptide. To further confirm the molecular weight
in Escherichia coli (4.6 1 108 U/mg).of the recombinant boIL-1b protein and to assess
whether the signal sequence was cleaved, a Western
Expression of boIL-1b lacked effect on virus growth
blot was performed (Fig. 5B). BoIL-1b produced by
in cell culture
BHV1/IL1b had a molecular weight comparable to our
To assess the growth efficiency of the recombinantrBoIL-1b standard of 19.3 kDa, indicating that the sig-
nal sequence was cleaved. BHV/IL1b virus, a single-step growth experiment was
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administering multiple injections at a localized site is
required for an adjuvant effect (Gao et al., 1995). The
construction of a recombinant BHV-1 expressing boIL-
1b cytokine has the potential to overcome these draw-
backs by delivering the cytokine to the site of infection.
This would allow the cytokine to act within a limited
microenvironment, reducing dose requirements and
thereby decreasing the chances of possible side-effects.
Our recombinant BHV/IL1b virus expressed the boIL-
1b gene from the gC locus similar to a late class gene
by utilizing the gC promoter (Fig. 3). This parallels gC
mRNA kinetics where gC transcripts are first detected at
5 hr followed by a sharp increase at 6 hr coinciding with
DNA synthesis (Seal et al., 1992). The transcripts also
produced a boIL-1b protein with a molecular weight of
19.3 kDa (Fig. 5B). This was comparable to both our
rBoIL-1b standard and the molecular weight previously
reported for the recombinant mature form of boIL-1b
(Maliszewski et al., 1988).
The bioassay results confirmed that indeed the boIL-
1b protein was biologically active possessing a specific
activity similar to rBoIL-1b produced in E. coli. We also
FIG. 2. Southern blot analysis of BHV/IL1b and wild-type BHV-1 DNA. tested the cellular fraction and detected biological activ-
Wild-type genomic DNA (wt.) and BHV/IL1b genomic DNA (mu.) were ity that was comparable to the supernatant fraction (data
digested with EcoRI and BglII. Two sets of digested samples, along not shown). Although IL-1 activity was not detectable
with DNA size markers were separated on a 1% agarose gel and
at 12 hr within the supernatant, the kinetics of mRNAtransferred to a nitrocellulose filter. One set of samples was probed
expression indicates that boIL-1b could be produced inwith a 0.6-kbp SmaI– BamHI fragment from pSD113SSIL-1b corre-
sponding to the 5* region of the gC gene (A); and a second set of small amounts after 6 hr. We speculate that since the
samples was probed with a 0.5 SmaI–BamHI fragment coding for the expression of IL-1 will occur at the site of infection, a
IL-1b gene from pSD113SSIL-1b (B).
performed. MDBK cells were infected with wild-type BHV-
1, gC-negative mutant and BHV/IL1b. At various time
points postinfection, supernatant samples were har-
vested and assayed for virus. As shown in Fig. 7, the
gC deletion mutant and BHV/IL1b exhibited comparable
growth kinetics; compared with wild-type virus, both mu-
tants yielded about a 10-fold lower virus titer at 24 hr
postinfection. Although BHV/IL1b appears to replicate
slightly better than gC-negative virus in this experiment,
multiple experiments showed no statistically significant
differences between these viruses. The observation that
BHV/IL1b and the gC deletion mutant had similar growth
curves indicates that the expression of boIL-1b does not
affect the virus growth in vitro.
DISCUSSION
The use of cytokines as adjuvants for modulating the
immune response against BHV-1 has been investigated
FIG. 3. Transcription kinetics of BoIL-1b in virus-infected cells. Atin both subunit and modified live vaccines (Reddy et al.,
various time points postinfection, RNA samples were prepared and run1993; Hughes et al., 1992; Gao et al., 1995). Although the
on a 1.2% agarose gel (bottom figure). To confirm RNA integrity andresults have been promising, the systemic administration
approximate concentrations per lane, duplicate samples were stained
of rBoIL-1b to develop an adjuvant effect usually requires with ethidium bromide; 18S and 28S RNA bands are shown on top.
a large dose which sometimes results in toxic side-ef- Molecular size markers in kilobases are noted to the left. M indicates
mock-infected cells at 10 hr.fects (Reddy et al., 1993; Godson et al., 1995). In addition,
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FIG. 5. Detection of bovine interleukin-1b by immunoprecipitation
assay and Western blot. (A) MDBK cells were infected with either BHV1/
IL1b (mu.) or wt BHV-1 (wt.) at an m.o.i. of 10 and labeled with 50 mCi
of [35S]methionine per milliliter. After 24 hr of labeling, cellular and
medium fractions were harvested separately and immunoprecipitated
using bovine IL-1b-specific rabbit antiserum. (B) Western blot analysis
of boIL-1b. BHV/IL-1b supernatant was concentrated to 2 ng of boIL-
1b per lane, denatured, and resolved by electrophoresis on a 10%
polyacrylamide–SDS gel. rBo-IL1b at 2 ng per lane was used as a
control. Molecular weight markers are indicated on the left margin.
FIG. 4. Indirect immunofluorescence demonstrating subcellular loca-
tion of boIL-1b. MDBK cells were infected with BHV/IL1b at a m.o.i. of sequence (Fig. 1B). Based on the observation that a gC
0.01 for 16 hr. Cells were fixed with 2% paraformaldehyde, permeabil-
mutant lacking the transmembrane and cytoplasmic do-ized with methanol, and incubated with rabbit anti-boIL1b serum at a
main regions is effectively secreted from infected cells1:500 dilution followed by incubation with fluorescein-labeled goat anti-
rabbit antibody. Original magnification, 2501. (Liang et al., 1993), we speculate that the processing
and secretion of gC-boIL-1b was either not interacting
completely with the ER/Golgi complex or some other fac-
small amount of cytokine produced by BHV1/IL-1b tor was interacting with the gC-boIL1b protein to prevent
should create a milieu consisting of infected cells plus effective secretion.
cells which are directly or indirectly stimulated by the In vitro growth experiments indicated that the produc-
cytokine. tion of boIL-1b was not toxic to the cells and did not
We found that boIL-1b expressed by BHV/IL1b was
both cell-associated and secreted into the medium (Fig.
5A). A significant proportion of boIL-1b still remained cell
associated even after infection at a high m.o.i. Immuno-
fluorescence showed that the majority of this cell-associ-
ated IL-1 was located in the cytoplasm. In this regard,
expression of boIL-1b by the recombinant virus differs
from normal IL-1b expression, since the 17.5-kDa mature
cytokine is rarely found in high concentrations within the
cell (Hazuda et al., 1988). In monocytes, IL-1b is initially
synthesized as a 31-kDa precursor that is cleaved by an
ICE to generate the mature cytokine which is the major
biological active form (Kostura et al., 1989; Black et al.,
1989; Thornberry et al., 1992; Cerretti et al., 1992). The
actual mechanism of transport outside of the cell is un-
FIG. 6. Bioassay for bovine IL-1b expression. Confluent monolayersknown, but it has been suggested to be linked with cleav-
of MDBK cells in 100-mm plates were infected with wild-type BHV-1,age of the precursor into the mature form by ICE via a
gC-negative mutant, and recombinant BHV/IL1b at a m.o.i. of 5. Atnonclassical pathway (Howard et al., 1995). The finding
indicated times, the supernatants were harvested. Samples were as-
that a significant proportion of the boIL-1b remained in sayed for IL-1b activity using a subclone (LM-1) of the D10.G4.1 ATCC
the cell was unexpected since the mature sequence of cell line sensitive to interleukin-1. The results represent means { S.D.
of triplicate samples.the boIL-1b gene was fused to the gC signal peptide
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